EdX

Drug Discovery in Prevention and Treatment of COVID-19 (edX)

Drug Discovery in Prevention and Treatment of COVID-19 (edX)

This curriculum includes research into fundamental knowledge of clinical diagnosis, prevention and treatment of COVID-19. The beginning of 2020 have witnessed the emergence of COVID-19 escalating to a world pandemic. This virus have claimed more than 100,000 death reported by WHO, 10 times more than the seasonal flu does. Since the severity of the virus is becoming crystal clear, it is essential to grasp related knowledge to prepare us for self-protection and future drug development.

Class Deals by MOOC List - Click here and see EdX's Active Discounts, Deals, and Promo Codes.

Faculty in School of Pharmaceutical Sciences Tsinghua University, partnering with the Global Health Drug Discovery Institute (GHDDI) has been rapidly organizing to set up this curriculum – drug discovery in prevention and treatment of COVID-19 – in order to provide information about virus detection and our ways of fighting against the ongoing outbreak.

What you'll learn
This curriculum includes research into fundamental knowledge of clinical diagnosis, prevention and treatment of COVID-19. Different strategies for drug development targeting this virus, the specific virus-host interaction of COVID-19 and how artificial intelligence (AI) contributes to the drug discovery will also be introduced during our lessens. In addition, Tsinghua University now open free access to researchers, clinicians and policymakers, hoping to offer some insights to responders around the world to be better equipped.

Go to Class
MOOC List is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Related Courses

Industrial Biotechnology (Coursera) Coursera
University of Manchester

Industrial Biotechnology (Coursera)

Fossil fuels have been the primary energy source for society since the Industrial Revolution. They provide the raw material for the manufacture of many everyday products that we take for granted, including pharmaceuticals, food and drink, materials, plastics and personal care. As the 21st century progresses we need solutions for the manufacture of chemicals that are smarter, more predictable and more sustainable.

Nov 2nd 2026
5-12 Weeks
Strategies for Assisted Living Communities during COVID-19 (Coursera) Coursera
Johns Hopkins University

Strategies for Assisted Living Communities during COVID-19 (Coursera)

SARS-CoV-2, the virus that causes COVID-19, poses a high risk for assisted living communities due to residents’ age, health status, and communal living environment. The COVID-19 response has largely focused on nursing homes, leaving assisted living communities in the United States with fragmented guidance on how to respond to COVID-19 challenges. This course provides comprehensive instruction and resources for administrators and direct-care staff of assisted living communities.

Nov 9th 2026
1 Week
Physics of COVID-19 Transmission (edX) EdX
MIT,MITx

Physics of COVID-19 Transmission (edX)

Learn about the scientific principles behind the airborne transmission of COVID-19, and how quantitative safety guideline may be derived to assess the risk of transmission. Since the beginning of the pandemic of coronavirus disease 2019 (COVID-19), there has been significant public confusion and scientific controversy over the modes of transmission and the most effective methods to protect against them, as reflected in changes in public health guidance.

Self Paced
Self-Paced
Introduction to Small Molecule Drug Discovery & Development (Coursera) Coursera
University of Cape Town

Introduction to Small Molecule Drug Discovery & Development (Coursera)

What does it take to advance a new drug from the laboratory bench to the patient’s bedside? Historically, drugs were discovered serendipitously and were usually isolated from natural sources. Today, drug discovery efforts take many years and cost hundreds of millions of dollars. They also require the input of dozens of specialists from a multitude of backgrounds to ensure that therapeutic molecules are efficacious and safe.

Nov 9th 2026
4 Weeks
Managing Supply Chain Disruption During COVID-19 (Coursera) Coursera
University of Illinois at Urbana-Champaign

Managing Supply Chain Disruption During COVID-19 (Coursera)

In this course, you will learn about why and how supply chains become susceptible to a disruption. We will examine this by discussing supply side and demand side issues, primary supply chain flows, complexity, risk management and a combination of solid theoretical supply chain perspectives and current real-world stories. You will learn about the structural, relational and operational factors that come into play during a supply chain disruption and the mechanisms for the effective management of these factors.

Nov 9th 2026
4 Weeks
Innovate & Regulate: Drug Research, Costs, Clinical Trials & Approval (edX) EdX
Davidson College,DavidsonX

Innovate & Regulate: Drug Research, Costs, Clinical Trials & Approval (edX)

At some point in their life, essentially everyone needs to use medication for some type of disease treatment or cure. While medications offer great benefits, the cost of drugs, especially new drugs, and the lack of treatment for some diseases can raise questions about business activity behind the creation of new drugs. Better understanding of how drugs are discovered and developed as well as the legal and regulatory factors that affect the industry can help one better recognize both the shortcomings and opportunities faced by the drug industry at large.

Self Paced
Self-Paced
Case Studies in Personalized Medicine (Coursera) Coursera
Vanderbilt University

Case Studies in Personalized Medicine (Coursera)

Learn how advances in biomedicine hold the potential to revolutionize drug development, drug treatments, and disease prevention: where are we now, and what does the future hold? This course will present short primers in genetics and mechanisms underlying variability in drug responses. A series of case studies will be used to illustrate principles of how genetics are being brought to bear on refining diagnoses and on personalizing treatment in rare and common diseases. The ethical and operational issues around how to implement large scale genomic sequencing in clinical practice will be addressed.

Nov 9th 2026
5-12 Weeks